Skip to main content
eClinicalMedicine logoLink to eClinicalMedicine
. 2023 Jan 30;56:101841. doi: 10.1016/j.eclinm.2023.101841

Corrigendum to ‘Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial’

Robin von Rotz a,, Eva M Schindowski a, Johannes Jungwirth a, Anna Schuldt a, Nathalie M Rieser a, Katharina Zahoranszky a, Erich Seifritz b, Albina Nowak b, Peter Nowak b, Lutz Jäncke c, Katrin H Preller a,d, Franz X Vollenweider a,d
PMCID: PMC9898017  PMID: 36747965

We wish to provide a correction of the colour representation of Fig. 2 in order to harmonise the colours representing the Psilocybin and the Placebo condition with the corresponding figure caption and with the colour codes from all other figures across the manuscript. Fig. 2 now depicts the Psilocybin condition in blue and the Placebo condition in yellow. The error occurred as a result of an oversight. This change does not affect the results presented in the paper and the figure legend remains unchanged.

graphic file with name fx1.jpg


Articles from eClinicalMedicine are provided here courtesy of Elsevier

RESOURCES